BridgeMD
New treatment option for Stage III Periodontitis
Official title Active Oxygen Releasing Gel With Photodynamic Therapy in Treating Stage III Periodontitis
ClinicalTrials.gov ID: NCT07368699
What this study is testing
- What it's testing
- Periodontitis is a serious gum disease that can damage the tissues supporting the teeth. The standard treatment is scaling and root planing of the teeth and roots.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 70
You may be able to join if
- Patients with periodontal diagnosis of stage III periodontitis
- Patients with residual periodontal pocket depth ≥4 mm ,CAL≥ 5mm with bone loss extending to middle third of root and beyond in radiography
- Bleeding on probing at least four sites at base-line
- Patients who didn't receive periodontal treatment for a minimum of 3 months prior to the examination.
- Patients of both sexes aged ≥30 and ≤70 years
You likely can't join if
- Smokers or those with any other harmful habits such as pipe or vape smoking
- Patients with any systemic condition that will possibly affect the outcome of periodontal therapy i.e. (diabetic patients)
- Patients who have received any local or systemic anti-inflammatory medications or antibiotics within the last 6 months
- Pregnant or lactating women
- Patients with parafunctional habits
The study team makes the final eligibility decision.
Where it's taking place
- Alexandria, Bab Sharq, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Alexandria, Bab Sharq, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.